Pulsenmore Receives FDA De Novo Marketing Authorization for Home-Use Prenatal Ultrasound, Pioneering a New Era of Prenatal Care in the U.S.

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Pulsenmore-FDA

More Like This

PR Newswire associated0

Pulsenmore Expands Partnership with Clalit Health Services to Deliver 25,000 Home Ultrasound Devices for Remote Prenatal Care

Pulsenmore Receives Brazilian ANVISA Approval for Its Prenatal Home Ultrasound Solution

PR Newswire associated0

Pulsenmore Expands Its Fertility Platform into the UK

Pulsenmore is expanding the application of its home ultrasound solution for pregnant women: a clinical trial with Michigan Medicine will focus on the remote assessment of the fetal biophysical profile

PR Newswire associated0

Mindray Debuts Next-Generation BeneVision V Series Patient Monitoring System at Euroanaesthesia 2025

Masimo SafetyNet® and Saint-Denis Hospital Center, Delafontaine (France) (Photo: Business Wire)

Saint-Denis Hospital Center in France Implements Masimo SafetyNet® Telemonitoring to Facilitate Early Discharge of Premature Newborns from the Hospital

Pulsecare Medical's nsPFA clinical trial receives satisfactory short-term follow-up results

Pulsecare Medical's nsPFA clinical trial receives satisfactory short-term follow-up results